Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes

被引:150
|
作者
Petroff, MGV
Egan, JM
Wang, XL
Sollott, SJ
机构
[1] NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Intramural Res Program,NIH, Baltimore, MD 21224 USA
[2] NIA, Diabet Sect, Gerontol Res Ctr, Intramural Res Program,NIH, Baltimore, MD 21224 USA
[3] Univ Nacl La Plata, Fac Ciencias Med, Ctr Invest Cardiovasc, La Plata, Buenos Aires, Argentina
关键词
cardiac myocytes; glucagon-like peptide-1; cAMP; calcium;
D O I
10.1161/hh1701.095716
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The gut hormone, glucagon-like peptide-1 (GLP-1), which is secreted in nanomolar amounts in response to nutrients in the intestinal lumen, exerts cAMP/protein kinase A-mediated insulinotropic actions in target endocrine tissues, but its actions in heart cells are unknown. GLP-1 (10 nmol/L) increased intracellular cAMP (from 5.7+/-0.5 to 13.1 +/- 0.12 pmol/mg protein) in rat cardiac myocytes. The effects of cAMP-doubling concentrations of both GLP-1 and isoproterenol (ISO. 10 nmol/L) on contraction amplitude, intracellular Ca2+ transient (CaT), and pH(i) in indo-1 and seminaphthorhodafluor (SNARF)-1 loaded myocytes were compared. Whereas ISO caused a characteristic increase (above baseline) in contraction amplitude (160+/-34%) and CaT (70+/-5%), GLP-1 induced a significant decrease in contraction amplitude (-27+/-5%) with no change in the CaT after 20 minutes. Neither pertussis toxin treatment nor exposure to the cGMP-stimulated phosphodiesterase (PDE2) inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine or the nonselective PDE inhibitor 3-isobutyl-1-methylxanthine nor the phosphatase inhibitors okadaic acid or calyculin A unmasked an ISO-mimicking response of GLP-1. In SNARF-1-loaded myocytes, however, both ISO and GLP-1 caused an intracellular acidosis (Delta pH(i) -0.09+/-0.02 and -0.08+/-0.03, respectively). The specific GLP-1 antagonist exendin 9-39 and the cAMP inhibitory analog Rp-8CPT-cAMPS inhibited both the GLP-1-induced intracellular acidosis and the negative contractile effect. We conclude that in contrast to beta -adrenergic signaling, GLP-1 increases cAMP but fails to augment contraction, suggesting the existence of functionally distinct adenylyl cyclase/cAMP/protein kinase A compartments, possibly determined by unique receptor signaling microdomains that are not controlled by pertussis toxin-sensitive G proteins or by enhanced local PDE or phosphatase activation. Furthermore, GLP-1 elicits a cAMP-dependent modest negative inotropic effect produced by a decrease in myofilament-Ca2+ responsiveness probably resulting from intracellular acidification.
引用
收藏
页码:445 / 452
页数:8
相关论文
共 50 条
  • [31] Glucagon-like peptide-1 and islet lipolysis
    Winzell, MS
    Ahrén, B
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) : 795 - 803
  • [32] Glucagon-like peptide-1 and energy homeostasis
    Burcelin, Remy
    Cani, Patrice D.
    Knauf, Claude
    JOURNAL OF NUTRITION, 2007, 137 (11): : 2534S - 2538S
  • [33] Glucagon-like peptide-1, a matter of taste?
    Mojca Jensterle
    J. Hans DeVries
    Tadej Battelino
    Saba Battelino
    Bulent Yildiz
    Andrej Janez
    Reviews in Endocrine and Metabolic Disorders, 2021, 22 : 763 - 775
  • [34] Extrapancreatic effects of glucagon-like peptide-1
    Papazafiropoulou, A.
    Pappas, S.
    Papanas, N.
    ARCHIVES OF HELLENIC MEDICINE, 2014, 31 (06): : 686 - 692
  • [35] Glucagon-like peptide-1, learning, and neuroprotection
    不详
    NEUROSCIENTIST, 2004, 10 (01): : 10 - 10
  • [36] The Cardiovascular Biology of Glucagon-like Peptide-1
    Drucker, Daniel J.
    CELL METABOLISM, 2016, 24 (01) : 15 - 30
  • [37] The Glucagon-Like Peptide-1 Receptor-or Not?
    Pyke, Charles
    Knudsen, Lotte Bjerre
    ENDOCRINOLOGY, 2013, 154 (01) : 4 - 8
  • [38] Glucagon-like peptide-1 in the pathogenesis of obesity
    Naslund, E
    Hellstrom, PM
    DRUG NEWS & PERSPECTIVES, 1998, 11 (02) : 92 - 97
  • [39] CHARACTERIZATION OF THE GASTRIC RECEPTOR FOR TRUNCATED GLUCAGON-LIKE PEPTIDE-1 IN THE RAT
    UTTENTHAL, LO
    BLAZQUEZ, E
    DIABETOLOGIA, 1989, 32 (07) : A550 - A551
  • [40] Expression of the glucagon-like peptide-1 receptor gene in rat brain
    Alvarez, E
    Roncero, I
    Chowen, JA
    Thorens, B
    Blazquez, E
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 (03) : 920 - 927